CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-21 | Morris Richard Steven Chief Financial Officer | Purchase | +2,171 | $13.82 | $30K | 5,454 |
| 2021-05-21 | Goldsmith Bruce A CEO and President | Purchase | +2,000 | $13.12 | $26K | 5,983 |
| 2021-05-17 | Fotopoulos Alexandros Chief Technical Officer | Grant or award · Restricted Stock Unit (RSU) | +50,000 | 50,000 | ||
| 2021-03-22 | Salinas Eliseo Oreste Chief Res. & Develop Officer | Grant or award · Employee Stock Option (Right to buy) | +275,000 | 275,000 | ||
| 2021-03-22 | Salinas Eliseo Oreste Chief Res. & Develop Officer | Grant or award · Restricted Stock Unit (RSU) | +40,000 | 40,000 | ||
| 2021-03-22 | Salinas Eliseo Oreste Chief Res. & Develop Officer | Grant or award · Restricted Stock Unit (RSU) | +60,000 | 60,000 | ||
| 2021-03-15 | Romano Gary Chief Medical Officer | Option exercise | +10,000 | $8.07 | $81K | 10,000 |
| 2021-03-15 | Romano Gary Chief Medical Officer | Sale | −8,383 | $20.95 | $176K | 1,617 |
| 2021-03-15 | Romano Gary Chief Medical Officer | Sale | −1,617 | $21.86 | $35K | 0 |
| 2021-03-15 | Romano Gary Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) | −10,000 | 300,821 | ||
| 2021-02-18 | GOWEN MAXINE Director | Grant or award · Stock Option (right to buy) | +33,836 | 33,836 | ||
| 2021-02-16 | Quigley Jill M. Chief Operating Officer | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2021-02-16 | Morris Richard Steven Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-02-16 | Romano Gary Chief Medical Officer | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2021-02-16 | Cale Edgar B. GC and Corporate Secretary | Grant or award · Stock Option (right to buy) | +170,997 | 170,997 | ||
| 2021-02-16 | Goldsmith Bruce A CEO and President | Grant or award · Stock Option (right to buy) | +262,000 | 262,000 | ||
| 2021-02-16 | Fotopoulos Alexandros Chief Technical Officer | Grant or award · Stock Option (right to buy) | +105,000 | 105,000 | ||
| 2021-01-20 | Quigley Jill M. Chief Operating Officer | Sale | −1,300 | $30.01 | $39K | 295,284 |
| 2021-01-14 | Quigley Jill M. Chief Operating Officer | Sale | +16,298 | $30.10 | $491K | 296,584 |
| 2020-03-24 | Countouriotis Athena Director | Purchase | +10,000 | $14.98 | $150K | 18,900 |
Page 10 of 14 · 264 trades